YILMAZ, N. Et Al. 2016. Malignancy risk in scleroderma patients treated with cyclophosphamide. 4th Systemic Sclerosis World Congress .

YILMAZ, N., EMMUNGİL, H., GÜCENMEZ, S., ÖZEN, G., YILDIZ, F., BALKARLI, A., ... KİMYON, G.(2016). Malignancy risk in scleroderma patients treated with cyclophosphamide . 4th Systemic Sclerosis World Congress

YILMAZ, NESLİHAN Et Al. "Malignancy risk in scleroderma patients treated with cyclophosphamide," 4th Systemic Sclerosis World Congress, 2016

YILMAZ, NESLİHAN Et Al. "Malignancy risk in scleroderma patients treated with cyclophosphamide." 4th Systemic Sclerosis World Congress , 2016

YILMAZ, N. Et Al. (2016) . "Malignancy risk in scleroderma patients treated with cyclophosphamide." 4th Systemic Sclerosis World Congress .

@conferencepaper{conferencepaper, author={NESLİHAN YILMAZ Et Al. }, title={Malignancy risk in scleroderma patients treated with cyclophosphamide}, congress name={4th Systemic Sclerosis World Congress}, city={}, country={}, year={2016}}